Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
Identifieur interne : 002A93 ( Istex/Curation ); précédent : 002A92; suivant : 002A94Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
Auteurs : Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2001-03.
English descriptors
- KwdEn :
Abstract
Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders. © 2001 Movement Disorder Society.
Url:
DOI: 10.1002/mds.1069
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002A93
Links to Exploration step
ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title><author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name><affiliation wicri:level="1"><mods:affiliation>Istituto di Neurologia, Università Cattolica, and Istituto Nazionale Neurologico, Milano, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Neurologia, Università Cattolica, and Istituto Nazionale Neurologico, Milano</wicri:regionArea></affiliation></author><author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name><affiliation wicri:level="1"><mods:affiliation>Clinica Neurologica, Università di Pisa, Pisa, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinica Neurologica, Università di Pisa, Pisa</wicri:regionArea></affiliation></author><author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name><affiliation wicri:level="1"><mods:affiliation>Laboratoire de Pharmacologie Médical et Clinique, INSERM U455, Toulouse, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Pharmacologie Médical et Clinique, INSERM U455, Toulouse</wicri:regionArea></affiliation></author><author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, King's College Hospital, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurology, King's College Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name><affiliation wicri:level="1"><mods:affiliation>Dipartimento di Scienze Neurologiche, Università La Sapienza, Roma, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Dipartimento di Scienze Neurologiche, Università La Sapienza, Roma</wicri:regionArea></affiliation></author><author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name><affiliation wicri:level="1"><mods:affiliation>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps‐Universität Marburg, Germany</mods:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps‐Universität Marburg</wicri:regionArea></affiliation></author><author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Beilinson Medical Centre, Sackler Medical School, Tel‐Aviv, Israel</mods:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Neurology, Beilinson Medical Centre, Sackler Medical School, Tel‐Aviv</wicri:regionArea></affiliation></author><author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name><affiliation wicri:level="1"><mods:affiliation>Service de Neurologie, Université J. Fourier, Grenoble, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Neurologie, Université J. Fourier, Grenoble</wicri:regionArea></affiliation></author><author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurology, Leiden University Medical Centre, Leiden</wicri:regionArea></affiliation></author><author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name><affiliation wicri:level="1"><mods:affiliation>Clinica Neurologica, Università di Catanzaro, Catanzaro, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinica Neurologica, Università di Catanzaro, Catanzaro</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7E</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1002/mds.1069</idno><idno type="url">https://api.istex.fr/document/3638D905253CBADE5F33953F6B488F265CEAEE7E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002A93</idno><idno type="wicri:Area/Istex/Curation">002A93</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title><author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name><affiliation wicri:level="1"><mods:affiliation>Istituto di Neurologia, Università Cattolica, and Istituto Nazionale Neurologico, Milano, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Neurologia, Università Cattolica, and Istituto Nazionale Neurologico, Milano</wicri:regionArea></affiliation></author><author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name><affiliation wicri:level="1"><mods:affiliation>Clinica Neurologica, Università di Pisa, Pisa, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinica Neurologica, Università di Pisa, Pisa</wicri:regionArea></affiliation></author><author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name><affiliation wicri:level="1"><mods:affiliation>Laboratoire de Pharmacologie Médical et Clinique, INSERM U455, Toulouse, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Pharmacologie Médical et Clinique, INSERM U455, Toulouse</wicri:regionArea></affiliation></author><author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, King's College Hospital, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurology, King's College Hospital, London</wicri:regionArea></affiliation></author><author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name><affiliation wicri:level="1"><mods:affiliation>Dipartimento di Scienze Neurologiche, Università La Sapienza, Roma, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Dipartimento di Scienze Neurologiche, Università La Sapienza, Roma</wicri:regionArea></affiliation></author><author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name><affiliation wicri:level="1"><mods:affiliation>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps‐Universität Marburg, Germany</mods:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps‐Universität Marburg</wicri:regionArea></affiliation></author><author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Beilinson Medical Centre, Sackler Medical School, Tel‐Aviv, Israel</mods:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Neurology, Beilinson Medical Centre, Sackler Medical School, Tel‐Aviv</wicri:regionArea></affiliation></author><author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name><affiliation wicri:level="1"><mods:affiliation>Service de Neurologie, Université J. Fourier, Grenoble, France</mods:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Neurologie, Université J. Fourier, Grenoble</wicri:regionArea></affiliation></author><author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands</mods:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurology, Leiden University Medical Centre, Leiden</wicri:regionArea></affiliation></author><author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name><affiliation wicri:level="1"><mods:affiliation>Clinica Neurologica, Università di Catanzaro, Catanzaro, Italy</mods:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinica Neurologica, Università di Catanzaro, Catanzaro</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2001-03">2001-03</date><biblScope unit="vol">16</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="197">197</biblScope><biblScope unit="page" to="201">201</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">3638D905253CBADE5F33953F6B488F265CEAEE7E</idno><idno type="DOI">10.1002/mds.1069</idno><idno type="ArticleID">MDS1069</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson disease</term><term>apomorphine</term><term>diagnosis</term><term>levodopa</term><term>treatment</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders. © 2001 Movement Disorder Society.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A93 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 002A93 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7E
|texte= Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |